Skip to main content

Advanced Search

Advanced Search

Current Filters

Filter your query

Publication Types

Other

to

Grant

/

Addressing High Prescription Drug Prices: Advancing Policy Solutions and Looking Ahead to Solve Complicated Problems

Grant Details

Grantee Organization
Waxman Consulting, Inc.

Principal Investigator
William Corr, J.D.

Term
8/1/19 - 7/31/20

Award Amount
$315,250

Approval Year

Related Program
Controlling Health Care Costs

Topics
Health System Performance and Costs

Grant Details

Grantee Organization
Waxman Consulting, Inc.

Principal Investigator
William Corr, J.D.

Term
8/1/19 - 7/31/20

Award Amount
$315,250

Approval Year

Related Program
Controlling Health Care Costs

Topics
Health System Performance and Costs

The project seeks to support federal policymakers in advancing drug pricing policy in 2019 and 2020 and to provide continuing education to lawmakers about the key drivers of U.S. pharmaceutical spending. It will provide: analysis and commentary on policy proposals and activity on drug pricing; technical assistance on policy solutions under consideration and education on larger issues in drug pricing; and an update of a previously published Fund report with new data, including pricing trends and updated solutions to inform debate leading into the 2020 election cycle.

Related Grants

Strategies and Resources for Assessing State-Focused Commercial Prices

Planning Phase for Study Tour of Singapore, New Zealand, and Australia

Leveraging Value-Based Payments to Improve Drug Spending, Utilization, and Equity